galactosamine has been researched along with dexmedetomidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ao, J; He, L; Huang, Y; Li, X; Wang, A; Wang, C; Yang, C | 1 |
| He, XJ; Huang, S; Liu, MH; Xie, B | 1 |
2 other study(ies) available for galactosamine and dexmedetomidine
| Article | Year |
|---|---|
Dexmedetomidine alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury in mice.
Topics: Animals; Chemical and Drug Induced Liver Injury; Dexmedetomidine; Galactosamine; Lipopolysaccharides; Liver; Male; MAP Kinase Kinase 4; Mice, Inbred BALB C; Protective Agents; Tumor Necrosis Factor-alpha | 2019 |
[Dexmedetomidine alleviates LPS/D-Gal-induced acute liver injury via up-regulation of LC3-II expression in mice].
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Dexmedetomidine; Galactosamine; Interleukin-6; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Tumor Necrosis Factor-alpha; Up-Regulation | 2021 |